3rd Annual Phrmaceutical and Biotec Middle East (PABME) Exhibition & Conference from 23rd May

3rd Annual PABME Exhibition & Conference will offer pharmaceutical and biotechnology scientists and practitioners from around the world the opportunity to interact, network and exchange ideas for the betterment of the profession and bring themselves and their organisation to the forefront of the discipline.

PABME will be held at Sheikh Maktoum Hall of Dubai WTTC from Sunday 23 May Monday 24 May Tuesday 25 May 2010

PABME is a truly multinational platform with exhibitors from around the world giving participants the opportunity for exposure, seldom seen in other regionally based meetings, enabling commercial networking alongside scientific.

The newly initiated steering and advisory committee led by industry experts, is in the process, in its advisory capacity, of contributing to what will become an outstanding conference programme. Consisting of a variety of sessions, interactive workshops and tutorials covering a wide range of interesting topics for industry practitioners and professionals, the programme provides an excellent platform upon which international industry leaders can meet.

Overview of The PABME

With the inclusion of the PHARMA section from Arab Health, PABME has increased in both size and profile, with more exhibitors, visitors and world-wide speakers than ever before. The event now provides a one-stop shop for the pharmaceutical and biotechnology industry in the region.

The size and structure of the future Middle Eastern pharmaceutical and biotechnology market will be influenced by the purchasing power of people in the region and different Governments’ efforts to reform the industry.

The big picture:

Bahrain – Demand for sophisticated pharmaceuticals is high, particularly for cardiovascular, diabetes, cancer and endocrine therapy areas.

Egypt – Promising biotech sector emerging, with main focus on biogenerics
Iran – Tentative signs of market opening up to foreign products
Jordan – Local pharmaceutical companies are becoming important regional players, with ambitions to expand into international markets
Lebanon – Promising opportunities for foreign biotech products are emerging
Qatar – Despite small size, rapid growth of pharmaceutical market will encourage multinationals and regional companies
Saudi Arabia – Strong overall demand for branded pharmaceuticals will continue
Syria – Pharmaceutical market will remain a stronghold for local manufacturers
UAE – Emirates such as Abu Dhabi appear prepared to find significant resources to finance R&D in the pharmaceutical and biotechnology fields and seek to attract the world’s best partners as evidenced by statements in the Abu Dhabi Economic Vision 2030
Yemen – Pharmaceutical market remains reliant on imports, but success of foreign companies will be most likely through local alliances

Conferences Program

PABME brings together senior decision-makers, potential investors, scientists, technicians, marketeers and sales professionals who all work to make the pharmaceutical and biotechnology industry the success it is. The conferences play an important part in this, establishing PABME as a must-attend event for everyone, as well as a vital platform for participants to gain and exchange knowledge through the extensive conference programmes. The 2010 conference will offer delegates a high-brow programme with an extensive range of topics that will run alongside the exhibition.

Clinical Trials Congress 25 May 2010

Clinical research is rapidly expanding throughout the region. As an integral part in the development of the new drugs and technologies designed to better meet the needs of patients; this conference takes delegates step by step through the overall process and study phases; Highlighting i ssues in regulation, ethics, informed consent, GCP, compliance, inspections and investigator and sponsor responsibilities. Getting reliable, effective and successful trail results depend on healthcare providers and their commitment and knowledge of good clinical practices. Learn how you can be involved in the cutting edge research that will determine the future of medicine.

Pharmaceutical Registration 23 & 24 May 2010

To increase the market for your products you must be able to meet the high standards for regulatory approval. This congress takes you through the significant procedures to meet international and regional regulatory standards. The conference will also give a detailed review of current good manufacturing practice for methods to be used in, and the facilities or controls to be used for, the manufacture, processing, packing, or holding of a drug. Delegates will learn strategies for achieving successful implementation of a process validation program, staying in compliance and maintaining a validated state. Also how to prepare for regulatory pre-approval inspections and teaches participants main tools for evaluating CGMP compliance and pre-approval inspection (PAI) readiness. You will gain insight into avoiding the problems and pitfalls that commonly occur and how to get through this rigorous process it successfully.

Current Trends in Modern Pharmaceuticals and Biotechnology & Complementary and Alternative Medicine 24 & 25 May 2010

This free to attend conference is specially designed for healthcare providers, nurses and pharmacists to learn about the developments in the Pharmaceutical and Biotechnology industries. As an invaluable part of the healthcare chain it is essential to stay ahead of the
most up-to-date trends taking place and see how they can be used to better serve their patients.

ClinTec Academy for Clinical Research Excellence (ACRE) Workshop 23 & 24 May 2010

This workshop aims to provide the participants with a clearer understanding of global clinical trial-related regulations and provides an insight into ethical considerations in clinical trials involving human subjects. It is also designed to cover monitoring which is a quality control process within clinical trials and discusses various aspects to Quality Assurance within clinical trials. This workshop has been regionally accredited for 11 (eleven) CME hours by the Dubai Health Authority. (Accreditation Number 0444/10)

Basic Medication Safety (BMS) Certification Course 23 or 24 May 2010

The Basic Medication Safety (BMS) Certification Course was developed by the Saudi Medication Safety Centre (SMSC) – King Abdul Aziz Medical City (KAMC)-National Guard Health Affairs (NGHA) in the Kingdom of Saudi Arabia. BMS is the first and the only medication safety course for all healthcare providers dealing with the medication use process. The BMS course is endorsed by the world-renowned medication safety organization, the Institute of Safe Medication Practices (ISMP-USA). It is a half-day course with five (5) CME approved hours from the Saudi Council of Health Specialties.

Best Practices in Pharma & Bio (includes Pharmacovigilance) 23 & 24 May 2010

This free to attend conference is designed for pharmaceutical and biotechnology professionals to improve end-to-end management of their business. The two-day event will focus on pharmaceutical marketing, opportunities and challenges, quality assurance and pharmacovigilance. Limited spaces available.

Leave a comment